William R. Short, MD, MPH
Infectious Diseases
Accepting new patients
Sees patients age 18 and up
Penn Infectious Diseases Penn Presbyterian
Penn Medicine Provider

About me

  • Associate Professor of Clinical Medicine (Infectious Diseases)
  • Associate Professor of Clinical Medicine in Obstetrics and Gynecology

Education and training

  • Medical School: Hahnemann University School of Medicine
  • Residency: Hahnemann University Hospital
  • Fellowship: Hahnemann University Hospital

What my patients think about me

Average Rating

172 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

January 2026
very concerned
January 2026
dr short is kind, encouraging and informative
January 2026
he asks probing questions to unearth problems and offers solutions that are amazing
December 2025
understanding.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Short is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Orkin C, Paterson A, Elias A, Smuk M, Ring K, Volny-Anne A, Calmy A, Hazra A, Geretti AM, Radix A, Titanji BK, Spire B, Del Rio C, Foster C, Moore CB, Cortes CP, Mussini C, Kuritzkes DR, Tan DHS, Martinez E, Wit FWNM, Cresswell F, Venter WDF, Levy I, Zucker J, Molina JM, Hoy J, Arribas J, Llibre JM, Currier J, Rockstroh J, Sutinen J, Gebo K, Waters L, Gisslen M, O'Reilly M, Boffito M, Thompson M, Parczewski M, John M, Gandhi M, Kumarasamy N, Paton N, Mackie N, Cahn P, Elion R, Noe S, Walmsley S, Collins S, Cole-Haley S, Apea V, Short WR, Gilleece Y, Paparini S. Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process , Lancet HIV, 12(9): 2025,e649-e659


Maguire C, Rueve K, Farmer E, Huesgen E, Karaj A, Binkley A, Mounzer K, Brizzi M, Chary P, Sung P, Graziani A, Hiserodt E, Baron J, Koenig H, Short WR Real-World Virologic Outcomes in Patients with Elevated Body Mass Index Receiving Long Acting Cabotegravir/Rilpivirine , Clinical Infectious Diseases, 81(1): 2025,67-74


Zapata Vaca M, Tsosie CR, Logue-Chamberlain E, Coutifaris P, Christensen T, Mabry AB, Mohamed O, Tedaldi E, Oliver EA, Short WR, Lowenthal ED "My body my baby": a qualitative study examining drivers of infant-feeding choices among women living with HIV in Philadelphia, United States , AIDS Care: 2025,Epub ahead of print


Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related Weight Gain , Clinical Infectious Diseases, 80(3): 2025,602-612


Richterman A, Aitcheson N, Durnwald C, Curley C, Short WR, Jean Louis M, Momplaisir F, Thirumurthy H. Mental Bandwidth is Associated with HIV and Viral Suppression Among Low-Income Women in Philadelphia , AIDS Behavior, 29(2): 2025,556-561


Mantas S, O'Bryan J, Giles ML, Short WR, Logue-Chamberlain E, Krishnaswamy S Barriers to Clinician Reporting to the Antiretroviral Pregnancy Registry From Within and Outside the United States , Open Forum Infectious Diseases, 12(2): 2025,ofaf023


Short WR, Zimmerman MM, Mohamed O, Mofenson LM. Safety Data Timelines for Pregnant Individuals with HIV on Antiretroviral Therapy , Clinical Infectious Diseases, 79(6): 2024,1472-1474


Meanley S, Carter WB, Short WR, Metzger DS, Anorato A, Montaner LJ, Dube K HIV Clinical Providers’ Awareness, Attitudes, and Willingness to Support Patient Outreach Efforts for HIV Cure–Directed Research in Philadelphia, United States , Open Forum Infectious Diseases, 11(12): 2024,ofae687


Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, Pérez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy , Pharmacotherapy, 44(5): 2024,360-382


Gandhi M, Hill L, Grochowski J, Nelson A, Koss CA, Mayorga-Munoz F, Oskarsson J, Shiels M, Avery A, Bamford L, Baron J, Short WR, Hileman CO Case Series of People with HIV on the Long-Acting Combination of Lenacapravir and Cabotegravir: Call for a Trial , Open Forum Infectious Diseases, 11(4): 2024,ofae 125